CCSG Developmental Funds Awards
The Cancer Center Support Grant (CCSG) Developmental Funds Award (DFA) is funded through Georgetown Lombardi’s CCSG, which is in turn funded by the NIH. The purpose of the award is to encourage the initiation of promising new cancer-related projects leading to peer-reviewed funding and/or high-impact publications.
Developmental funds support basic, translational, clinical, and population science research as well as the Center’s Community Outreach and Engagement (COE) and Cancer Research Training and Education Coordination (CRTEC) activities by providing opportunities to investigate innovative research with an emphasis on strategic priorities for multi-PI collaboration across the Georgetown Lombardi Comprehensive Cancer Center consortium.
The grant is a one-year award of $10,000 to $50,000 and is not renewable. Developmental funds are available to all LCCC members with a cancer relevant research focus, including basic, clinical, translational, or population sciences with the exception that investigators who have received developmental funds twice within the last five years will not be eligible for additional funds.
- Projects should aim to achieve Cancer Center strategic objectives and focus on one or more of the following areas of research:
- Cancer-related health disparities and issues within the LCCC catchment area and/or underrepresented minorities
- Cancer and aging
- Survivorship research
- Correlative science associated with an investigator-initiated clinical trial derived from cancer center science
- Global oncology
- Advancement of a target/biomarker along the translational pipeline (from bench to bedside or vice versa)
- Intersection of Cancer and Infection
How to Apply
Information is circulated annually to Georgetown Lombardi members about how to apply to the CCSG Development Funds Awards (DFA).